Photochromic immunoassay for tumor marker detection based on ZnO/AgI nanophotocatalyst

A photochromic immunoassay was built for tumor marker detection based on ZnO/AgI nanophotocatalyst. Frist, ZnO/AgI nanoparticles were synthesized and characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray powder diffraction (XRD), and Fourier transform infrared spectrometry (FTIR). The color development is caused by tetramethyl benzidine (TMB) solution oxidated by ZnO/AgI nanomaterials. The electron transitions in ZnO/AgI nanomaterials are driven by visible light irradiation, generating photogenerated hole and oxidizing TMB to blue solution. Appropriate band width between ZnO and AgI promotes separation of photogenerated electrons and holes and enhances oxidation efficiency. A sandwich-type immunoassay was constructed based on ZnO/AgI nanomaterial as labels. The absorbance at 650 nm of reaction solution is positively correlated with antigen concentration. The developed immunoassay showed good performance for carcinoma embryonic antigen (CEA) detection in the range 0.1-7.0 ng/mL with a detection limit of 65 pg/mL. The photochromic immunoassay also exhibited preferable selectivity, repeatability, and stability.

Automated summary

A photochromic immunoassay based on ZnO/AgI nanophotocatalyst was developed for tumor marker detection. The color development is achieved by the oxidation of tetramethyl benzidine (TMB) solution by ZnO/AgI nanomaterials driven by visible light irradiation. A sandwich-type immunoassay using ZnO/AgI nanomaterial as labels showed good performance for the detection of carcinoma embryonic antigen (CEA).